| FNARX | RYEAX | FNARX / RYEAX | |
| Total Expense Ratio | 0.69 | 1.62 | 43% |
| Annual Report Gross Expense Ratio | 0.69 | 1.67 | 41% |
| Fund Existence | 29 years | 28 years | - |
| Gain YTD | 37.508 | 41.040 | 91% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 2500 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 919M | 27.5M | 3,342% |
| Annual Yield % from dividends | 1.78 | 2.16 | 82% |
| Returns for 1 year | 53.96 | 50.91 | 106% |
| Returns for 3 years | 80.48 | 48.10 | 167% |
| Returns for 5 years | 230.94 | 178.35 | 129% |
| Returns for 10 years | 175.46 | 79.51 | 221% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| BPLSX | 17.99 | 0.15 | +0.84% |
| Boston Partners Long/Short Equity Instl | |||
| RYCIX | 134.83 | 0.80 | +0.60% |
| Rydex Consumer Products Inv | |||
| MIGFX | 41.43 | 0.19 | +0.46% |
| MFS Massachusetts Inv Gr Stk A | |||
| FBTAX | 50.47 | N/A | N/A |
| Fidelity Advisor Biotechnology A | |||
| ARYVX | 14.90 | -0.02 | -0.13% |
| American Century Global Real Estate Inv | |||